Skye Bioscience, Inc. (SKYE)

1.16 +0.08 (+7.41%) USD  |  NASDAQ  |  Dec 16, 13:43
More

Skye Bioscience Total Expenses (Annual)

Total Expenses (Annual) Chart

View Total Expenses (Annual) for SKYE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (Annual) Range, Past 5 Years

View Total Expenses (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (Annual) Benchmarks

View Total Expenses (Annual) Benchmarks
Start Trial
Assertio Holdings, Inc. Upgrade
Harrow, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
FibroGen, Inc. Upgrade